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Abstract 1 
Background: Functional data analysis (FDA) is a forecasting approach that, to date, has not 2 
been applied to obesity, and that may provide more accurate forecasting analysis to manage 3 
uncertainty in public health.  The aim of this paper was to use FDA to provide projections of 4 
Body Mass Index (BMI), overweight and obesity in an Australian population through to 5 
2019.  6 
Methods: Data from the South Australian Monitoring and Surveillance System (January 2003 7 
to December 2012, n=51,618 adults) were collected via telephone interview survey.  FDA 8 
was conducted in four steps: (1) age-gender specific BMIs for each year were smoothed using 9 
a weighted regression; (2) the functional principal components decomposition was applied to 10 
estimate the basis functions; (3) an exponential smoothing state space model was used for 11 
forecasting the coefficient series; (4) forecast coefficients combined with the basis function. 12 
Results: The forecast models suggest that between 2012 and 2019, average BMI will increase 13 
from 27.2kg/m2 to 28.0kg/m2 in males and 26.4kg/m2 to 27.6kg/m2 in females.  The 14 
prevalence of obesity is forecasted to increase by 6-7 percentage points to 2019 (to 28.7% in 15 
males and 29.2% in females). 16 
Conclusions: Projections identify age-gender groups at greatest risk of obesity over time. 17 
The novel approach will be useful to facilitate more accurate planning and policy 18 
development. 19 
Key words: obesity, body mass index, forecasting, Functional Data Analysis 20 
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Introduction 21 
The rapid rise in obesity has been well documented internationally (1-2).  For example, the 22 
United States has maintained an historical record of the rise in obesity through its National 23 
Health and Nutrition Examination Survey (NHANES) series.  In the 1960s, the prevalence of 24 
overweight and obesity was about 45 precent and has steadily increased to a point where now 25 
the latest figures suggest almost three quarters of American adults are overweight or obese 26 
(3-4) and 35 percent are obese (5).  Population monitoring in other industrialised countries 27 
including Australia, France and the UK, has also tracked this rise, albeit at a lower prevalence 28 
than the USA (6-8).  Australia’s monitoring in nationally representative samples has been 29 
sporadic, but shows overweight and obesity has increased from 56.3 percent in 1995 to 62.8 30 
percent in 2011-12.  As a subset of this, the proportion of Australians who are obese has 31 
increased from 18.7 percent to 27.5 percent (9). 32 
Projection analysis undertaken as part of the OECD Economics of Prevention (2009) used 33 
national health survey data from 12 countries to estimate overweight and obesity prevalence 34 
for 2014 and forward to 2019.  Generally, the results suggest stabilization in rates of 35 
overweight, but continuing increases in obesity.  The Australian projections used data from 36 
four national surveys (1989-2005) and the forecasted rates of overweight and obesity were 37 
estimated to be about 60 percent in 2014 and 65 percent in 2019 (1).  However, recent 38 
national health survey data shows Australia has surpassed the 2014 projections and is fast 39 
approaching the estimated prevalence for 2019 – almost five years early (9). 40 
Time series forecasting is used as a practical planning tool for governments to help manage 41 
future uncertainty, and inform health policy change.  It is most useful when it is based on 42 
quality data and uses robust statistical methods.  Functional data analysis (FDA) is one such 43 
approach starting to receive attention in the literature, particularly in terms of its public health 44 
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and biomedical applications (10-12), but has yet to be applied to obesity.  Commonly, time 45 
series data are treated as multivariate data because they are given as a discrete time series, 46 
and important information about the smooth functional behaviour of generating trend analysis 47 
tends to be ignored.  FDA has the advantage of generating models that can be described by 48 
continuous smooth dynamics.  It uses effective data noise reduction through curve smoothing 49 
techniques, which then allow for more accurate estimates of parameters for use in the 50 
forecasting analysis. 51 
The aim of this paper is to apply FDA to 10 years of population survey data to provide 52 
projections of overweight and obesity in South Australia forward to 2019.  This outlook will 53 
allow comparison with other international projections provided by the OECD Economics of 54 
Prevention but will also be a useful time frame to facilitate government planning and policy 55 
development. The objectives of this paper are firstly to describe the past trends (2003-2012) 56 
and future projections (through to 2019) in body mass index, overweight and obesity 57 
prevalence rates in South Australia; and secondly to identify particular age-gender subgroups 58 
of the population at higher risk of obesity. 59 
  60 
4 
 
Methods 61 
Sample 62 
Data were collected using the South Australian Monitoring and Surveillance System 63 
(SAMSS) from January 2003 to December 2012.  The population of South Australia is about 64 
one and a half million (in 2011), accounting for 7.5 percent of the total Australian population 65 
(13).  The SAMSS is a Computer Assisted Telephone Interview survey that monitors self-66 
reported trends in risk factors, disease, and other health service issues.  Interviews are 67 
conducted on a minimum of 600 randomly selected people each month.  All households in 68 
South Australia with a telephone connected and the telephone number listed in the Electronic 69 
White Pages are eligible for selection.  A letter introducing the survey is sent to the selected 70 
household and the person with the last birthday within a 12-month period is chosen for 71 
interview.  Interviews are conducted with people of all ages, using parent-proxies for children 72 
under 16 years of age.  Up to ten call backs were made to the household to interview the 73 
selected persons, with no replacements were made for non-respondents.  Interviews were 74 
conducted by trained health interviewers.  To ensure the SAMSS data is representative, the 75 
data were weighted by age, gender and area (metropolitan/rural) of residence to reflect the 76 
structure of the South Australian population in the Australian Census and the probability of 77 
selection in the household.  Weighting was corrected for disproportionality of the sample 78 
with respect to the population of interest.  This weighting is based on a random selection of 79 
households and one person within the household (14).  The method is described in more 80 
detail elsewhere (14). 81 
From January 2003 to December 2012, 65,557 interviews were conducted with participants 82 
from birth through to 102 years of age (participation rate ranged from 60-70 percent).  This 83 
paper is limited to data collected from 51,618 adults (18 years and over).  This represent all 84 
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adults records in the survey (the expected total of 72,000, that is 600 per month over 10 years 85 
(2003-12) includes children). The sample size ranged from 4502 to 5401 people per year, was 86 
50.3 percent female overall, and had a relatively even distribution across the age groups 87 
(Supplementary Table 1).  88 
The interview questions of relevance to this paper included self-reported height and weight 89 
and personal details such as age and gender (Ethics approval number: HREC 479/11/2014). 90 
Body Mass Index and weight status 91 
BMI was calculated (in kg/m2) and converted to weight status categories using the World 92 
Health Organization cut-offs (15).  Data were categorised into three weight status groups: 93 
underweight and healthy weight (BMI less than 25kg/m2), overweight (greater than or equal 94 
to 25kg/m2 and less than 30kg/m2) and obese (greater than or equal to 30 kg/m2) (15).  Nine 95 
extreme BMI values (less than 13kg/m2 or greater than 97kg/m2) were excluded from the 96 
analysis based on cut-offs provided by the Australian Bureau of Statistics, consistent with 97 
those used in the recent National Health Survey (16) and personal communication.  98 
The BMI data were normally distributed therefore mean and standard deviations were used to 99 
summarise the data.  Percentages were used to describe the proportions of the population in 100 
each weight status category across age and gender.  Past differences in BMI between groups 101 
at single time points were assessed using Analysis of Variance (ANOVA) with Bonferroni 102 
adjustments.   103 
Forecasting framework – Functional Data Analysis 104 
The FDA approach was applied to model and forecast average BMI, overweight and obesity 105 
prevalence rates. Generally, this approach involved four interrelated steps that can be 106 
summarised as follows: (a) model the reported discrete data by smoothing technique and 107 
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construct smooth continuous functional observations. This emphasizes patterns in the data by 108 
minimizing short-term deviations due to observational errors, such as measurement errors or 109 
inherent system noise; (b) apply functional decomposition technique onto the smoothed 110 
functional observations to estimate the time-invariant basis functions and the associated time 111 
series coefficients. This decomposition is obtained by transforming the data to a new set of 112 
variables, or principal components that are uncorrelated and ordered so that the first few 113 
retain most of the variation present in all of the original dataset; (c) A standard time series 114 
technique to model and forecast the time series coefficients; and (d) combine the resulting 115 
time series forecasts with the time-invariant basis functions and generate forecasts of BMI, 116 
overweight and obesity for each year. 117 
To implement these steps, following the convention in FDA,  the observed average BMI or 118 
overweight and obesity prevalence rates for age x in year t, 𝑦𝑡 (𝑥), are described as 119 
.  The  is an underlying BMI smooth function of x observed 120 
with error,  is an independently and identically distributed standard normal random 121 
variable and  allows the variance to change with age and year according to the nature of 122 
the data. The second equation   describes the 123 
dynamics of evolving through time. In this equation,  is the mean of smooth BMI 124 
curves  across years and  is the model error.  The age component  is a set of 125 
orthogonal basis functions or principal components which modifies the main time trend 126 
according to whether change at a particular age is faster or slower than the main trend and in 127 
the same or opposite direction).  The model assumes that   is invariant over time. The 128 
time component,  are time series coefficients which capture the overall time trend in 129 
 at all ages.  The model makes no assumptions about the functional form of the trend in 130 
. 131 
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Although a number of methods have been used (17-20), the age-gender BMIs for each year 132 
were smoothed using weighted regression splines (11) to estimate the age–BMI curves. Since 133 
the BMI increased rapidly up to certain age and then declined, the BMI curves were assumed 134 
to concave with age. To capture the concave trends in BMI, constrained concavity (21) 135 
applied to smooth curves were used according to the method of Hyndman and Ullah (11). 136 
The use of weighted regression splines has a number of advantages in that: (a) the 137 
smoothness conditions can easily be adopted to the nature of the BMI data analysed, thereby 138 
reducing the noise in the BMI curves; and (b) the underlying process generating the age–BMI 139 
curves is then continuous and smooth. Once the required smoothed functions are generated, 140 
the resulting series were subsequently decomposed into optimal number of orthogonal 141 
functional principal components (FPC) and their associated time series coefficients using 142 
FPC technique (11). As all parameters on the right-hand side of second equation are 143 
unobservable, fitting the model using the ordinary least square method is impossible. To 144 
overcome the situation, FPC decomposition was applied to the smoothed BMI curves. 145 
Finally, given that time series coefficients are uncorrelated, we generated forecast for each 146 
time series separately. To keep the forecasts within acceptable confidence bounds, we limited 147 
the forecast interval to 7 years or 28 quarters, and generated forecasts on BMI for each 148 
quarter from 2013 to 2019. An exponential smoothing state space model selectio n algorithm 149 
(22,23) was used for forecasting BMI time series coefficients. Combine the forecasted time 150 
series coefficients with their corresponding basis functions to obtain forecast of BMI. All 151 
analyses were performed using R version 13.0 (24,25). 152 
 153 
Forecast accuracy 154 
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The accuracy of forecast was evaluated by computing the integrated squared prediction error, 155 
 x hnn dxxehISPE )()(
2
,  where )(ˆ)()( ,, xyxyxe hnhnhn    which denotes the prediction error. 156 
In designing the accuracy measures for the future age-specific BMI, an out-of-sample test 157 
was performed (26).  An out-of-sample evaluation of forecast accuracy begins with the 158 
division of the time series set into a fit period and a test period.  The fit period is used to 159 
identify and estimate an appropriate model, based on a set of the observed data for that period  160 
and does not involve any predictions.  The test period also uses observed data but this is 161 
compared to predictions arising from the model generated for the fit period and so measures 162 
the model’s prediction accuracy.  Based on the fitting period 2003–2010, the FDA forecasts 163 
of BMI for 2011–2012 were directly compared with the actual data for 2011–2012 through 164 
averaging of the Integrated Squared Forecast Error (ISPE) (11).   165 
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Results 166 
1. BMI 167 
Table 1 shows the trends in BMI, by age and gender, over the period 2003-2012.  The 168 
average BMI of males has increased from 26.7kg/m2 in 2003 to 27.2kg/m2 in 2012 (P=0.009) 169 
and from 25.8kg/m2 to 26.4kg/m2 for females (P=0.007).  Average BMI generally increased 170 
with age (P<0.001).  In males BMI peaked in the 45-54 year age group and females in the 55-171 
64 year age groups, before decreasing in the older age groups.  Over 10 years, South 172 
Australians aged 18-24 consistently reported the lowest BMI.  With one exception, males in 173 
2012, the average BMI for this age group has been below 25 (Table 1).   174 
Figure 1 shows the results of the functional data analysis showing the past rate of change in 175 
BMI by age and gender (Figures 1b and 1e) and the forecast coefficients for projecting future 176 
trends (Figures 1c and 1f).  The first basis function indicates that the rate of change in BMI 177 
from 2003-2012 has differed by gender.  Past trends show the greatest rate of increase has 178 
occurred in females aged 25-34 years (Figure 1b).  The peak in the basis function curve is 179 
more gradual and slightly lower in males than females, with the peak occurring over the 25-180 
34 and 35-44 year age groups and dropping off more gradually with age than for females 181 
(Figure 1e).  Based on these past trends, the forecast coefficients for males and females 182 
suggest a continuing positive increase in BMI through to 2019 (Figures 1c and 1f).   183 
Figures 2a and 2b shows the results of the forecasting analysis for BMI by gender and age 184 
group through to 2019, with each line representing the forecasted average BMI for the quarter 185 
(four per year), and the change in colour indicating a new year.  The forecast models suggest 186 
from 2013 to 2019 BMI will continue to increase.  Specifically, the average BMI will 187 
increase from 27.2 in males in 2012 to 28.0 in 2019 (0.8kg/m2), and from 26.4 to 27.6 188 
(1.2kg/m2) in females.  The projections (2013-2019) suggest marked increases are expected 189 
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in some age groups, particularly females around 30 years of age where an increase of over 190 
1kg/m2 is expected by 2019 (Figure 3a).   191 
2. Overweight 192 
Figure 4a shows a notable disparity in the prevalence of overweight between males and 193 
females across all years from 2003 to 2012.  In 2012, 45.6 percent of males were considered 194 
overweight and 27.9 percent of females.  The increase in prevalence of overweight with age 195 
is more gradual in females than males (Figures 5a and 5d), but the greatest rate of change in 196 
prevalence between 2003 and 2012 has occurred in the 25-34 year age groups in both 197 
genders.   198 
The prevalence of overweight in males overall has remained stable; 46.5 percent in 2003 and 199 
45.6 percent in 2012.  For females, the prevalence was 27.9 percent in 2003 and 2012 with a 200 
small increase in the years between (Supplementary Table 2).  Based on these past trends, the 201 
forecast coefficient for males and females is a flat line along the zero value (data not shown).  202 
The forecasting analysis of overweight by gender and age group shows little increase in the 203 
prevalence of overweight through to 2019.  Forecasting analysis suggests the prevalence of 204 
overweight across the population will be 46.1 percent in males and 30.1 percent in females. 205 
3. Obesity 206 
Different from overweight, the prevalence of obesity has tracked closely between males and 207 
females from 2003 of 2012 (Figure 4b).  A gradual increase in the prevalence of obesity has 208 
been observed, from 17.2 percent in males in 2003 to 21.6 percent in 2012, and 19.5 percent 209 
to 23.1 percent in females.  An increase in obesity prevalence with age is also evident, with 210 
the highest prevalence observed in the 55-64 year age group for both males and females 211 
(Supplementary Table 2).  212 
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The results of the FDA show a clear peak in the rate of change in obesity for females in the 213 
25-34 year age group (Figure 5b), compared to a more rounded peak across the 25-34 and 35-214 
44 year age groups for males (Figure 5e).  The rate of increase in obesity prevalence slowed 215 
with age.  Based on these trends, the forecast coefficients suggest a continuing increase in 216 
population prevalence of obesity through to 2019 (Figures 5c and 5f).  Overall, the forecast 217 
model suggests the prevalence of obesity in males is expected to increase by 7.1 percentage 218 
points (21.6 to 28.7 percent) and 6.1 percentage points in females (23.1 to 29.2 percent).  219 
Generally, the increase in obesity is gradual over the forecast years for males and females 220 
(Figures 2e and 2f).  The greatest increase in the prevalence of obesity is expected for 221 
females aged 25-34 years where the prevalence could reach 33 percent.  The greatest increase 222 
in males is in the mid 30s to mid 40s (Figure 3b), where the prevalence of obesity may reach 223 
almost 35 percent. 224 
  225 
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Discussion 226 
The obesity epidemic is considered one of the greatest public health challenges confronting 227 
Australia and other industrialised countries (26-28).  The rise in prevalence of obesity over 228 
the last decade presented in this paper supports national and international data (1-2, 7-8).  229 
However, to our knowledge, this is the first application of FDA to estimate future increase in 230 
BMI and obesity.  FDA is a novel, innovative trend forecasting tool which uses smoothing 231 
and noise reduction data techniques that should result in more accurate projections of obesity 232 
than alternative approaches, such as regression models.  We suggest that without major 233 
intervention the average BMI of the Australian adult population will continue to increase 234 
(~0.5kg/m2 by 2019, but up to 1kg/m2 in some groups) and the prevalence of obesity could 235 
reach 33-34 percent in some sub-groups of the population.  The estimates of the prevalence of 236 
overweight and obesity for 2019 were 67 percent (60 percent in females and 75 percent in 237 
males), two percent higher than previous projections (1).  This trajectory of predicted weight 238 
gain among adults, particularly in younger age groups, will have serious impacts on 239 
individuals’ quality of life.  The number of years lived with obesity has been shown to be 240 
associated with risk of cardiovascular disease related and all-cause mortality (29).  With more 241 
of the population becoming obese and at a younger age, the consequences of obesity will 242 
exert more pressure on over-stretched health care systems.   243 
Action is needed to ensure individuals stay within their weight status category and avoid the 244 
upwards slide into the overweight or obese categories.  Forecasting suggests that while 245 
overweight will plateau, overweight as a precursor to obesity is still of concern, particularly 246 
for men where 45 percent are currently overweight.  While this data are cross-sectional in 247 
nature and do not track weight gain in individuals, the upward shift in BMI of the population 248 
towards obesity has also been shown in longitudinal studies.  The AusDiab study recruited 249 
11,247 Australian adults (aged 25+ years) in 1999-2000 and followed them over a 12-year 250 
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period (~55 percent of sample participated in follow-up data collection).  The annual 251 
incidence of overweight was 2.6 percent and the annual incidence of obesity was 1.3 percent.  252 
For those individuals who were normal or overweight at baseline, 28.4 percent had 253 
progressed to a higher BMI category during follow-up.  The reverse was not common; that is 254 
few obese individuals moved to a lower BMI category at follow-up (30).   255 
Increases in BMI and obesity prevalence over the adult years for women relate to the 256 
reproductive transitions - during pregnancy (in the 30s) and menopause years (in the 50s) 257 
(31).  The rate of increase in obesity has been highest for women of mid-childbearing age 258 
(32), and notably in our study this increase occurred at a faster rate than men at this age; 259 
however for men it stays elevated through the 30s and into their mid 40s.  Longitudinal 260 
studies have also demonstrated that the rate of weight gain is highest amongst this age group 261 
of adults and declines with age (30,33).  In the AusDiab study, the average weight gain over 262 
12 years was 2.6kg for all age groups, however weight gain for those aged 25-34 years at 263 
baseline was 6.7kg compared to 0.4kg for those aged 55-64 years at baseline (30). 264 
While our data is limited to the South Australian population, the Australian Longitudinal 265 
Study on Women’s Health is a national population-based study, which also shows the rate of 266 
increase in BMI in greatest for young women of child bearing age (34).  Excess weight gain 267 
during pregnancy and failure to return to pre-pregnancy weight within six months postpartum 268 
are predictors of long-term obesity (35-36) and many women cite pregnancy as one of the 269 
life-course events associated with the advent of weight gain in adulthood.  Our projections 270 
suggest that, in the future, Australian mothers will be starting their pregnancy journey from a 271 
heavier baseline, which will further exacerbate weight management at this life stage.  Further 272 
to this, there is a link between maternal obesity and an increased risk of obesity in their 273 
children meaning future generations will be at a greater risk of obesity (37).  The FDA 274 
approach can effectively model the age-related changes in BMI over time, and therefore 275 
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allow predictions for specific age groups to be made (11).  The ability to identify sub groups 276 
across the whole population at greatest risk of obesity over time allows primary and 277 
secondary interventions to be targeted to particular life stages.  278 
Strengths and limitations 279 
This is the first published application of FDA to forecast overweight and obesity in an 280 
Australian or international population.  The approach of initially smoothing the data and then 281 
using the smoothed observations for modelling and prediction estimation is a major 282 
methodological improvement to fit linear/non-linear trends of observed prevalence rates.  A 283 
second strength of the FDA approach is the improved modelling of inconsistent increases in 284 
prevalence rates over time, and allows unstable trend and high variability of prevalence rates 285 
across ages to be captured in projections. 286 
The key strength of the data used in this modelling is the standardised data collection method 287 
used across many years, in a large representative sample.  However, in population surveys a 288 
common limitation is the use of self-reported height and weight which are subject to 289 
misreporting (38-39), and using self-reported measurements could underestimate the 290 
prevalence of overweight and obesity by 5 percent or more in males and female adults (40).  291 
Therefore in the context of our results, it is likely that the estimates of BMI and weight status 292 
are a conservative estimate of obesity, and the future prevalence may be even greater than 293 
projected.   294 
Our forecasting models have used data collected continuously over ten years for South 295 
Australia, which is one jurisdiction, and accounts for 7.5 percent of the total Australian 296 
population.  There are some differences in the demographic characteristics of South Australia 297 
compared to the Australia more generally, mainly as a consequence of the slightly older 298 
population (median age 39 vs 37 years nationally) (13) which influence estimates of 299 
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overweight and obesity slightly, but we believe the forecasting is valuable more broadly 300 
given the widespread nature of obesity.  Further forecasting analysis will examine other 301 
demographic sub-groups, as the most disadvantaged groups have been identified to be at 302 
greater risk of overweight and obesity (41-42).  Also, a random telephone survey approach 303 
was used to collect data for this study and has been used extensively in the past.  The 304 
increasing community reliance on the mobile network is thought not to impact on health 305 
estimates in telephone surveys (43), however this needs to be monitored to ensure telephone 306 
surveyed samples continue to be representative of the wider community. 307 
The BMI, overweight and obesity may be varied for changing the policy in public health 308 
setting. The FDA forecasting did not take into account the impact of change in public health 309 
policy within an obesogenic environment, especially at state level. Although observational 310 
errors have been reduced through smoothing technique in the cases of changing rates over 311 
time, the change in public health policy may impact on the accuracy of the model. 312 
Further research and action   313 
The worldwide obesity epidemic indicates that poor diet and lack of physical activity are 314 
replacing smoking as the key behavioural determinants of preventable disease (2, 44).  A 315 
vision for Australia to be the healthiest country by 2020 has been proposed but progress on 316 
implementing the full scope of the recommendations to reduce obesity has been limited (45).  317 
A comprehensive and integrated program of action to control population weight gain, at the 318 
level of the individual and environment, have been suggested (46-47), with strategies largely 319 
in line with the more recent nutrition and physical activity recommendations from the World 320 
Health Organization to prevent and manage non-communicable diseases that are major 321 
contributors to preventable mortality and morbidity (28).  Obesity needs to be at the forefront 322 
of all government agendas.  Past trends and future projections in Australia would suggest a 323 
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major investment or shake up in the approach is required to attenuate the anticipated increase 324 
in diseases associated with increases in overweight and obesity.  325 
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Figure 1. Principal Components From the Functional Data Analysis (FDA) for Male and 441 
Female BMI: the Mean BMI (Figures 1a and 1d), the First Basis Function (Figures 1b and 442 
1e) and the Coefficient Associated with the First Basis Function (Figures 1c and 1f). 443 
 444 
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Figure 2. Functional Data Analysis Forecast of Female and Male BMI (2a & 2b), Overweight 448 
(2c & 2d) and Obesity (2e & 2f), From January 2013 to December 2019. 449 
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Figure 3: Forecasted Change in BMI (Figure 3a) and the Forecasted Change in Prevalence of 457 
Obesity (Figure 3b) From January 2013 to December 2019. 458 
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Figure 4: Prevalence of Overweight (Figure 4a) and Obesity (Figure 4b) in Males and 462 
Females, Using the South Australian Monitoring and Surveillance System, January 2003 to 463 
December 2012.    464 
465 
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Figure 5. Principal Components From the Functional Data Analysis (FDA) for Male and 469 
Female Obesity: the Mean Prevalence of Obesity (Figures 5a and 5d), the First Basis 470 
Function (Figures 5b and 5e) and the Coefficient Associated With the First Basis Function 471 
(Figures 5c and 5f) 472 
473 
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Table 1: Average Body Mass Index by Age and Gender Groups, Using the South Australian Monitoring and Surveillance System, January 2003 475 
to December 2012.    476 
 477 
    2003 2004 2005 2006 2007 
  
Age 
group Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Male 18-24 24.94 (4.10) 23.83 (3.75) 24.19 (5.13) 24.50 (4.39) 23.60 (3.59) 
 
25-34 26.16 (4.02) 26.26 (4.13) 26.01 (3.78) 26.30 (4.45) 26.29 (4.52) 
 
35-44 27.34 (5.43) 27.54 (4.38) 26.86 (4.24) 27.37 (4.25) 27.91 (4.37) 
 
45-54 27.73 (4.69) 27.67 (4.95) 27.37 (4.42) 27.69 (4.76) 27.88 (4.26) 
 
55-64 26.99 (4.59) 27.82 (4.34) 27.55 (4.30) 27.73 (4.62) 27.78 (4.34) 
 
65+ 26.25 (3.82) 26.26 (4.28) 26.47 (4.96) 26.13 (4.06) 26.49 (4.02) 
Overall males 26.68 (4.60) 26.74 (4.53) 26.52 4.56) 26.76 (4.54) 26.86 (4.44) 
Female 18-24 23.27 (5.40) 23.00 (4.28) 23.24 (4.53) 23.04 (4.36) 22.99 (4.19) 
 
25-34 25.35 (5.86) 24.91 (5.45) 24.83 (5.41) 25.17 (5.50) 25.22 (5.29) 
 
35-44 25.98 (5.71) 25.92 (5.91) 25.89 (5.76) 26.74 (5.70) 26.45 (6.34) 
27 
 
 
45-54 26.39 (5.59) 26.64 (5.49) 27.09 (6.43) 26.54 (5.77) 27.47 (6.20) 
 
55-64 26.89 (5.37) 27.32 (5.42) 27.10 (5.81) 27.61 (5.73) 27.49 (5.68) 
 
65+ 26.07 (5.30) 26.09 (4.91) 25.74 (5.48) 26.07 (5.19) 26.24 (5.10) 
Overall females 25.78 (5.64) 25.80 (5.46) 25.79 (5.78) 26.03 (5.59) 26.21 (5.76) 
 478 
Table 1: continued 479 
    2008 2009 2010 2011 2012 
  
Age 
group Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Male 18-24 23.73 (4.43) 24.71 (4.29) 24.24 (3.92) 24.31 (5.17) 25.02 (4.82) 
 
25-34 26.85 (4.70) 25.86 (4.10) 26.77 (4.89) 26.76 (4.54) 27.06 (5.01) 
 
35-44 27.76 (4.76) 27.81 (4.73) 27.79 (4.59) 28.28 (4.98) 26.95 (4.70) 
 
45-54 28.25 (4.65) 28.19 (5.40) 28.20 (4.75) 28.51 (5.53) 28.01 (4.63) 
 
55-64 27.86 (4.81) 28.11 (4.89) 27.65 (4.53) 28.31 (4.75) 27.91 (4.58) 
 
65+ 26.42 (4.42) 26.73 (4.61) 26.97 (4.83) 26.74 (4.65) 27.23 (4.76) 
Overall males 27.02 (4.83) 27.04 (4.86) 27.12 (4.77) 27.34 (5.12) 27.18 (4.82) 
28 
 
Female 18-24 23.23 (4.87) 22.88 (4.59) 23.60 (4.80) 23.38 (5.11) 23.39 (5.10) 
 
25-34 25.24 (4.74) 26.16 (5.50) 25.62 (5.51) 26.19 (7.45) 25.40 (6.34) 
 
35-44 25.88 (5.69) 26.62 (5.69) 26.63 (5.62) 27.74 (6.91) 26.58 (5.84) 
 
45-54 27.35 (5.74) 27.43 (5.70) 27.81 (6.04) 28.20 (6.65) 27.42 (6.36) 
 
55-64 27.58 (5.58) 27.26 (5.51) 27.87 (5.89) 27.62 (5.57) 27.78 (5.85) 
 
65+ 26.42 (5.68) 26.48 (5.35) 26.85 (5.69) 26.71 (5.43) 26.58 (5.29) 
Overall females 26.12 (5.60) 26.37 (5.60) 26.60 (5.80) 26.88 (6.43) 26.40 (5.98) 
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